Epidemiology: Parkinson's Disease

Introduction

In this report, Datamonitor has estimated that there were a total of 1.5 million cases of Parkinson’s disease (PD) in 2010 in the seven major markets with nearly a third of them living in the US. Incidence rates are expected to remain constant, while total prevalence rates will increase as a result of the aging population in the seven major markets.

Features and benefits

• Gain insight to market potential, including a robust 10-year epidemiology forecast of prevalent Parkinson's disease cases.
• Understand the key epidemiologic risk factors associated with Parkinson's disease.

Highlights

Datamonitor expects an increase in prevalent PD cases in the next decade in the seven major markets as a result of an ageing population.Parkinson’s disease is a lifelong incurable yet non-fatal disease; its disease progression leads to an increasing healthcare burden and lower quality of life.Age, family history and environmental exposures are important determining factors in PD prevalence and; with the exception of Japan, men are at a higher risk of developing PD in the six remaining major markets

Your key questions answered

• What are the most robust epidemiologic studies for Parkinson's disease prevalence data?
• How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
• How do changes in population structure and risk factors affect the trend in prevalent Parkinson's disease cases?